NSE: BALRAMCHIN · 3 November 2026
- Balrampur Chini Mills has risen 11.08% over 2 trading sessions; today's move is +9.15%.
- Balrampur Chini Mills received a ₹75 crore grant assistance from BIRAC under the Department of Biotechnology, Government of India, for establishing a 100 TPA PLA co-polymer R&D facility. The pilot-scale facility will be set up at the company's integrated manufacturing complex in Kumbhi, Uttar Pradesh, to accelerate advanced bio-based material development.
- Trading volume was 7.45 times the 20-day average daily volume.
Balrampur Chini Mills share price: 11.08% rise over 2 trading sessions
Balrampur Chini Mills Ltd. (BALRAMCHIN) surged 9.15% today, closing at ₹654.80 after moving within a wide intraday range of ₹607.40 and ₹665.80.
The broader market and sectoral backdrop provided strong supportive momentum for the stock. The benchmark Nifty rose 1.58%, while the Nifty FMCG sector benchmark outperformed with a gain of 3.65%. Balrampur Chini significantly outpaced both benchmarks, reflecting robust buying interest that also follows a modest 5-day return of 3.67%, despite a 20-day return decline of -2.49%.
While no single company-specific operational announcement was published today, investor sentiment has been underpinned by recent strategic developments, including the Government of India's ₹75 crore BioE3 grant awarded in late September 2026 to back India's first PLA co-polymer R&D facility at its Kumbhi complex in Uttar Pradesh. Additionally, upcoming corporate triggers such as the board meeting scheduled for November 4, 2026, to review financial results and consider an interim dividend, along with an investor conference call slated for November 5, 2026, may have influenced pre-earnings market positioning.
77.22 lakh shares traded by 3 November 2026 · 03:25 PM IST. This compares with a 20-day average daily volume of 10.36 lakh shares (7.45 times). The five-day average daily volume was 6.34 lakh shares. Separately, the NSE report for 2 November 2026 showed 5.13 lakh shares delivered, representing 46.26% of that day’s traded volume. The same report recorded 41,939 trades.
The sharp 9.15% rally was accompanied by above-average trading volume and strong sectoral outperformance against the Nifty FMCG benchmark. While no direct single catalyst was announced today, upcoming financial results and interim dividend deliberations scheduled for November 4, 2026, likely drew heightened market attention.
Latest Company Developments
Balrampur Chini Mills received a ₹75 crore grant assistance from BIRAC under the Department of Biotechnology, Government of India, for establishing a 100 TPA PLA co-polymer R&D facility. The pilot-scale facility will be set up at the company's integrated manufacturing complex in Kumbhi, Uttar Pradesh, to accelerate advanced bio-based material development.
It strengthens the company's biomanufacturing capabilities and advances its long-term strategic diversification into sustainable polylactic acid production.
The company informed the stock exchanges that a meeting of the Board of Directors is scheduled for November 4, 2026, to consider and approve standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2026. The board will also consider the declaration of an interim dividend for the financial year 2026-2027.
Upcoming financial results and potential dividend announcements often drive pre-announcement trading activity and market positioning.
The company submitted the certified true copy of the minutes of its 50th Annual General Meeting held on September 16, 2026, which covered shareholder adoptions, executive re-appointments including Vivek Saraogi as Chairman and Managing Director, and the appointment of Vartika Shukla as an Independent Director.
Provides continuity in leadership and reinforces corporate governance standards across key managerial positions.
Balrampur Chini Mills Limited has informed that the Executive Committee of the Board of Directors of the Company have approved the allotment of 44287 equity shares of Re 1/- each of the Company, fully paid up, at their meeting held today, i.e., 24th October, 2026, to the employees of the Company pursuant to exercise of Employees Stock Appreciation Rights, as per BCML Employees Stock Appreciation Rights Plan 2023.
'Reminder intimation sent to the Physical Shareholders to update KYC details and Claim Unpaid/Unclaimed Dividends and Shares'.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 27.55% on 30 September 2026. This compares with 25.83% on 30 June 2026, a change of +1.72 percentage points.
The filing reported 29 MF/UTI holders.
Research & Brokerage Views
Analyst Ruchit Jain suggested Balrampur Chini as a near-term buy based on technical setup and market outlook.
Historical Bulk / Block Deals
What to Watch Next
- Outcome of the board meeting on November 4, 2026, regarding Q2FY27 financial results and interim dividend
- Management commentary and guidance during the investor conference call on November 5, 2026
- Execution progress on the upcoming PLA co-polymer R&D facility in Kumbhi, Uttar Pradesh
- Cash volume and delivery participation trends in subsequent trading sessions
Other Dated Coverage
More Balrampur Chini Mills news and dated analysis →
Frequently Asked Questions
What is the latest Balrampur Chini Mills company news?
Balrampur Chini Mills received a ₹75 crore grant assistance from BIRAC under the Department of Biotechnology, Government of India, for establishing a 100 TPA PLA co-polymer R&D facility. The pilot-scale facility will be set up at the company's integrated manufacturing complex in Kumbhi, Uttar Pradesh, to accelerate advanced bio-based material development.
How strong was Balrampur Chini Mills’s trading volume?
77.22 lakh shares traded, 7.45 times the 20-day average daily volume. The price and volume data are dated 3 November 2026 · 03:25 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.